Mentoring of Clinical Investigators in Patient Oriented Research
指导临床研究人员进行以患者为导向的研究
基本信息
- 批准号:7249107
- 负责人:
- 金额:$ 18.33万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-06-01 至 2012-05-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAgonistAnalgesicsAreaAwardBehavior TherapyBiological AvailabilityBuprenorphineCharacteristicsClassificationClinicalClinical InvestigatorClinical PharmacologyClinical ResearchClinical TrialsCocaineCocaine AbuseCocaine DependenceCommunitiesComorbidityDevelopmentDiseaseDoseDrug AddictionDrug abuseEnvironmentFacultyFellowshipFundingGoalsGrantHumanInterventionLaboratory StudyLeadMaintenanceMentorsMentorshipMissionNational Institute of Drug AbuseNew AgentsOpiate AddictionOpioidOralPatientsPersonal SatisfactionPersonsPharmaceutical PreparationsPharmacotherapyPhysical DependencePhysiciansPilot ProjectsPositioning AttributePsychiatryPurposeRangeRecruitment ActivityRelative (related person)ReportingResearchResearch PersonnelResourcesRoleSafetyScheduleScientific Advances and AccomplishmentsSeriesSubstance Use DisorderSubstance abuse problemSupport of ResearchSymptomsTestingTrainingTramadolUnited StatesUnited States Food and Drug AdministrationUnited States National Institutes of HealthUniversitiesWithdrawalWomanWorkaddictionbasecareerexperiencemedical schoolsmembermenmu opioid receptorsnext generationpatient oriented researchprescription documentprescription procedure
项目摘要
DESCRIPTION (provided by applicant): This is an application for a K24 Mid-career Investigator Award in Patient Oriented Research (POR). The applicant is Eric Strain, a physician-researcher in the Department of Psychiatry at Johns Hopkins University School of Medicine. Dr. Strain has devoted his career to POR, and specifically to issues related to research on drug abuse and to treatment of substance abusing patients. His areas of focus have included the development of medications for the treatment of opioid and cocaine dependence, the testing of medications combined with behavioral treatment interventions, the role of psychiatric symptoms and comorbidity in substance use disorders, the testing of abuse liability of medications, and the special treatment needs of women and men with substance abuse. This application describes the candidate's three immediate career goals (to recruit young physicians/clinical investigators to conduct research fellowships in clinical addictions research, to integrate these clinical investigators into ongoing and new studies of POR conducted at the BPRU by providing direct experience in all aspects of clinical investigation, and to assist and mentor these clinical investigators in the transition from fellow to junior faculty member, encouraging each to continue in a career path of addictions-related research). In addition, three long-term career goals are also described (to develop a group of junior, mid-level, and senior clinician investigators with expertise in conducting addictions-related research to serve as a next generation of investigators in substance abuse research at Johns Hopkins, to maintain current investigative strengths of the BPRU while building new complementary areas of clinical research through collaborative efforts within the research community, and to utilize this investigative team in advancing scientific understanding of addictive disorders and their treatment through coordinated efforts). These goals will be accomplished through currently funded research efforts, and a clinical pharmacology study is succinctly presented to illustrate work currently funded by the candidate. In addition, funds from the present application will be used for pilot studies to be conducted with young clinicians, and the research plan for a study comparing tramadol to buprenorphine for the treatment of opioid withdrawal is presented. This work is highly relevant to the mission of NIH and NIDA. Recruiting and training young clinical investigators in the area of addictions are needed to advance understanding and treatment of these disorders. The applicant is well positioned to recruit young clinical investigators, has experience in successfully mentoring young researchers, and is in a strong research environment with excellent resources for mentoring and providing high quality clinical research experiences.
描述(由申请人提供):这是一个K24职业中期研究者奖在面向患者的研究(POR)的应用程序。申请人是约翰霍普金斯大学医学院精神病学系的医生兼研究员埃里克·斯特兰。Strain博士致力于POR,特别是与药物滥用研究和药物滥用患者治疗相关的问题。他的重点领域包括阿片类药物和可卡因依赖治疗药物的开发,药物与行为治疗干预相结合的测试,精神症状和合并症在药物使用障碍中的作用,药物滥用倾向的测试,以及药物滥用的女性和男性的特殊治疗需求。这份申请描述了候选人的三个近期职业目标(招募年轻的医生/临床研究人员进行临床成瘾研究的研究奖学金,通过提供临床研究各方面的直接经验,将这些临床研究人员纳入BPRU正在进行的和新的POR研究,并协助和指导这些临床研究人员从研究员过渡到初级教员,鼓励每个人继续从事与成瘾相关的研究)。此外,还描述了三个长期职业目标(培养一批具有成瘾相关研究专业知识的初级、中级和高级临床研究人员,作为约翰霍普金斯药物滥用研究的下一代研究人员,保持BPRU目前的研究优势,同时通过研究界的合作努力建立新的补充临床研究领域,并利用这一调查小组,通过协调努力,促进对成瘾性疾病及其治疗的科学理解)。这些目标将通过目前资助的研究工作来实现,并简要介绍了临床药理学研究,以说明候选人目前资助的工作。此外,本申请的资金将用于与年轻临床医生进行的试点研究,并提出了比较曲马多与丁丙诺啡治疗阿片类药物戒断的研究计划。这项工作与NIH和NIDA的使命高度相关。需要招募和培训成瘾领域的年轻临床研究人员,以促进对这些疾病的理解和治疗。申请人有能力招募年轻的临床研究者,有成功指导年轻研究人员的经验,并且处于强大的研究环境中,拥有优秀的指导资源和提供高质量的临床研究经验。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Eric C. Strain其他文献
Diretrizes para o tratamento de pacientes com síndrome de dependência de opióides no Brasil
巴西
- DOI:
- 发表时间:
2004 - 期刊:
- 影响因子:0
- 作者:
D. A. Baltieri;Eric C. Strain;J. Dias;S. Scivoletto;André Malbergier;S. Nicastri;Cláudio Jerônimo;A. G. Andrade - 通讯作者:
A. G. Andrade
What is the most cost-effective advertising strategy for alcohol pharmacotherapy clinical trials?
- DOI:
10.1016/j.drugalcdep.2014.09.695 - 发表时间:
2015-01-01 - 期刊:
- 影响因子:
- 作者:
David A. Tompkins;Joseph A. Harrison;Eric C. Strain - 通讯作者:
Eric C. Strain
Clustering of multiple substance use and psychiatric diagnoses in opiate addicts.
阿片成瘾者多种物质使用和精神病诊断的聚集。
- DOI:
- 发表时间:
1991 - 期刊:
- 影响因子:4.2
- 作者:
Eric C. Strain;R. Brooner;George E. Bigelow - 通讯作者:
George E. Bigelow
Patient attitudes toward technology-assisted treatment during hospital-based dual-diagnosis treatment
- DOI:
10.1016/j.drugalcdep.2015.07.1156 - 发表时间:
2015-11-01 - 期刊:
- 影响因子:
- 作者:
Alexis S. Hammond;Eric C. Strain;Jeffrey Hsu;Denis G. Antoine - 通讯作者:
Denis G. Antoine
Randomized controlled evaluation of tramadol for opioid detoxification
- DOI:
10.1016/j.drugalcdep.2016.08.168 - 发表时间:
2017-02-01 - 期刊:
- 影响因子:
- 作者:
Kelly E. Dunn;D.A. Tompkins;George Bigelow;Eric C. Strain - 通讯作者:
Eric C. Strain
Eric C. Strain的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Eric C. Strain', 18)}}的其他基金
Mentoring of Clinical Investigators in Patient Oriented Research
指导临床研究人员进行以患者为导向的研究
- 批准号:
8656083 - 财政年份:2007
- 资助金额:
$ 18.33万 - 项目类别:
Mentoring of Clinical Investigators in Patient Oriented Research
指导临床研究人员进行以患者为导向的研究
- 批准号:
8064793 - 财政年份:2007
- 资助金额:
$ 18.33万 - 项目类别:
Mentoring of Clinical Investigators in Patient Oriented Research
指导临床研究人员进行以患者为导向的研究
- 批准号:
8458048 - 财政年份:2007
- 资助金额:
$ 18.33万 - 项目类别:
Mentoring of Clinical Investigators in Patient Oriented Research
指导临床研究人员进行以患者为导向的研究
- 批准号:
8858595 - 财政年份:2007
- 资助金额:
$ 18.33万 - 项目类别:
Mentoring of Clinical Investigators in Patient Oriented Research
指导临床研究人员进行以患者为导向的研究
- 批准号:
7426393 - 财政年份:2007
- 资助金额:
$ 18.33万 - 项目类别:
Mentoring of Clinical Investigators in Patient Oriented Research
指导临床研究人员进行以患者为导向的研究
- 批准号:
8300484 - 财政年份:2007
- 资助金额:
$ 18.33万 - 项目类别:
Mentoring of Clinical Investigators in Patient Oriented Research
指导临床研究人员进行以患者为导向的研究
- 批准号:
7618754 - 财政年份:2007
- 资助金额:
$ 18.33万 - 项目类别:
Mentoring of Clinical Investigators in Patient Oriented Research
指导临床研究人员进行以患者为导向的研究
- 批准号:
9067265 - 财政年份:2007
- 资助金额:
$ 18.33万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 18.33万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 18.33万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 18.33万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 18.33万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 18.33万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 18.33万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 18.33万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 18.33万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 18.33万 - 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
- 批准号:
23K05057 - 财政年份:2023
- 资助金额:
$ 18.33万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




